$14.97
4.18% day before yesterday
NYSE, Jan 02, 10:19 pm CET
Why the stock moved Why the stock moved Beta
ISIN
US6877931096
Symbol
OSCR
Sector
Industry

Oscar Health Target price 2026 - Analyst rating & recommendation

Oscar Health Classifications & Recommendation:

Buy
19%
Hold
31%
Sell
50%

Oscar Health Price Target

Target Price $13.77
Price $14.97
Deviation
Number of Estimates 14
14 Analysts have issued a price target Oscar Health 2027 . The average Oscar Health target price is $13.77. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 16 analysts: 3 Analysts recommend Oscar Health to buy, 5 to hold and 8 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Oscar Health stock has an average upside potential 2027 of . Most analysts recommend the Oscar Health stock at Sale.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 9.18 12.26
56.54% 33.58%
EBITDA Margin 0.97% -1.53%
127.87% 257.05%
Net Margin 0.28% -2.76%
106.00% 1,096.07%

14 Analysts have issued a sales forecast Oscar Health 2025 . The average Oscar Health sales estimate is

$12.3b
Unlock
. This is
8.60% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$12.7b 12.58%
Unlock
, the lowest is
$11.7b 3.61%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $9.2b 56.54%
2025
$12.3b 33.58%
Unlock
2026
$12.7b 3.56%
Unlock
2027
$14.5b 13.98%
Unlock
2028
$15.7b 8.15%
Unlock

13 Analysts have issued an Oscar Health EBITDA forecast 2025. The average Oscar Health EBITDA estimate is

$-187m
Unlock
. This is
3.85% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-147m 18.36%
Unlock
, the lowest is
$-228m 26.57%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $89.4m 143.63%
2025
$-187m 309.18%
Unlock
2026
$131m 170.16%
Unlock
2027
$454m 245.75%
Unlock
2028
$600m 32.20%
Unlock

EBITDA Margin

2024 0.97% 127.87%
2025
-1.53% 257.05%
Unlock
2026
1.03% 167.32%
Unlock
2027
3.14% 204.85%
Unlock
2028
3.83% 21.97%
Unlock

14 Oscar Health Analysts have issued a net profit forecast 2025. The average Oscar Health net profit estimate is

$-338m
Unlock
. This is
38.53% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-294m 20.34%
Unlock
, the lowest is
$-364m 49.06%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $25.4m 109.39%
2025
$-338m 1,429.73%
Unlock
2026
$-26.1m 92.27%
Unlock
2027
$261m 1,097.24%
Unlock
2028
$288m 10.53%
Unlock

Net Margin

2024 0.28% 106.00%
2025
-2.76% 1,096.07%
Unlock
2026
-0.21% 92.39%
Unlock
2027
1.80% 957.14%
Unlock
2028
1.84% 2.22%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.10 -1.29
108.20% 1,390.00%
P/E negative
EV/Sales 0.20

14 Analysts have issued a Oscar Health forecast for earnings per share. The average Oscar Health EPS is

$-1.29
Unlock
. This is
37.23% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.12 19.15%
Unlock
, the lowest is
$-1.39 47.87%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.10 108.20%
2025
$-1.29 1,390.00%
Unlock
2026
$-0.10 92.25%
Unlock
2027
$1.00 1,100.00%
Unlock
2028
$1.10 10.00%
Unlock

P/E ratio

Current -15.93 112.69%
2025
-11.57 27.35%
Unlock
2026
-149.76 1,194.38%
Unlock
2027
15.02 110.03%
Unlock
2028
13.59 9.52%
Unlock

Based on analysts' sales estimates for 2025, the Oscar Health stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.22 52.17%
2025
0.20 7.32%
Unlock
2026
0.20 3.43%
Unlock
2027
0.17 12.29%
Unlock
2028
0.16 7.53%
Unlock

P/S ratio

Current 0.35 16.43%
2025
0.32 7.92%
Unlock
2026
0.31 3.43%
Unlock
2027
0.27 12.27%
Unlock
2028
0.25 7.52%
Unlock

Current Oscar Health Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Stephens & Co.
Locked
Locked
Locked Dec 11 2025
Piper Sandler
Locked
Locked
Locked Nov 26 2025
Wells Fargo
Locked
Locked
Locked Nov 13 2025
Barclays
Locked
Locked
Locked Nov 10 2025
UBS
Locked
Locked
Locked Nov 07 2025
Goldman Sachs
Locked
Locked
Locked Oct 14 2025
Wells Fargo
Locked
Locked
Locked Oct 07 2025
Analyst Rating Date
Locked
Stephens & Co.:
Locked
Locked
Dec 11 2025
Locked
Piper Sandler:
Locked
Locked
Nov 26 2025
Locked
Wells Fargo:
Locked
Locked
Nov 13 2025
Locked
Barclays:
Locked
Locked
Nov 10 2025
Locked
UBS:
Locked
Locked
Nov 07 2025
Locked
Goldman Sachs:
Locked
Locked
Oct 14 2025
Locked
Wells Fargo:
Locked
Locked
Oct 07 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today